A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection
BackgroundEpstein–Barr virus (EBV) is a significant global public health concern because of its association with various malignancies and autoimmune diseases. Over 90% of the global population is chronically infected with EBV, impacting numerous cancer-related cases annually. However, none of the ef...
Saved in:
Main Authors: | Ping Li, Ziyi Jiang, Jingjing Shi, Haochuan Sha, Zihang Yu, Yan Zhao, Sanyang Han, Lan Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1530364/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection
by: Ping Li, et al.
Published: (2025-02-01) -
The probable progression of Epstein-Barr virus (EBV) to chronic active EBV/reactivation weakens the immune response and stimulates Cryptococcus neoformans infection, which invariably proves fatal: a case report and review of the literature
by: Gargee Mishra, et al.
Published: (2025-01-01) -
Comparison between ELISA and PCR for Detection of Epstein - Barr virus in children with acute cervical lymphadenitis
by: Nazim Khan, et al.
Published: (2024-11-01) -
Beyond immortality: Epstein–Barr virus and the intricate dance of programmed cell death in cancer development
by: Arezoo Esmaeili, et al.
Published: (2024-01-01) -
Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges
by: Febri Gunawan Sugiokto, et al.
Published: (2025-01-01)